Aly Razek
Washington University in St. Louis
12 Papers
117 Citations
Aly Razek is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Ewing's sarcoma & Sarcoma. The author has an hindex of 7, co-authored 11 publications.
Chat about Author
Papers
Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study.
Carlos A. Perez,Aly Razek,M. Tefft,Mark Nesbit,Burgert Eo,John M. Kissane,Teresa J. Vietti,Gehan Ea +7 more
TL;DR: Radiation therapy in combination with multiple chemotherapy is an effective treatment method to control Ewing's sarcoma locally and the late effects of this intensive combined therapy must be assessed in long term survivals.
61
An analysis of neuroblastoma at a single institution
Patrick R.M. Thomas,Patrick R.M. Thomas,Jeannette Y. Lee,Barbara Fineberg,Aly Razek,Carlos A. Perez,Vita J. Land,Teresa J. Vietti +7 more
TL;DR: The overwhelming influence of factors unrelated to treatment in determining the prognosis of neuroblastoma is confirmed and stage, histology, age at diagnosis, and site of primary tumor are independent prognostic variables.
29
Combined treatment modalities of rhabdomyosarcoma in children.
TL;DR: Thirty‐nine previously untreated children with rhabdomyosarcoma were managed by a coordinated program of surgery, radiation therapy, and chemotherapy during the years 1960 to 1973, with correlation of absolute survival with dose of irradiation, primary site, extent of disease and histologic subtypes of the tumor discussed.
26
Breast Cancer in the United Arab Emirates
Humaid O. Al-Shamsi,Nadia A Abdelmegeed Abdelwahed,Aydah Al-Awadhi,Mohamed Albashir,Amin Abyad,Saeed Rafii,M.A. El Afrit,Bilal Al Lababidi,Ibrahim Abu-Gheida,Yoginee Pundlik Sonawane,Neil A. Nijhawan,Urfan Ul Haq,Norbert Dreier,Thanda Joshua,Faryal Iqbal,Tamer G. Yacoub,Faisal A. Nawaz,Dima Abdul Jabbar,Syed Hammad Tirmazy,Dalia El-Shourbagy,Dina Hamza,Mohamed Omara,Sawsan Abdul Salam Al Madhi,Hassan Ghazal,Humaa Darr,Muharrem Oner,Zoi Vlamaki,Abdul Rahman El Kinge,Dorai Ramanathan,Mohammed Judah,Taghreed Almahmeed,Mudhasir Ahmad,Sai Jonnada,Nahla Almansoori,Aly Razek,Annett Al-Hamadi,Nahed Balalaa,Faek R. Jamali,R A Singarachari,Abdel Karim S. Labban,Kaltar Das,Ernest J. T. Luiten,Tamer Abdelgawad,Falah Al-Khatib,Sadir Alrawi,Hassan Jaafar +45 more
TL;DR: Humaid O. Al-Shamsi, MD, Nadia Abdelwahed, MD; Aydah Al-Awadhi, MD and Mohamed Albashir, MD as discussed by the authors .
7
•Journal Article
Effect of Dose Fractionation of Daunorubicin on Survival of Leukemic Cells
TL;DR: Mice bearing transplanted AKR leukemia received daunorubicin either as a single dose or as four equally divided doses with the time interval between the divided doses varying from 12 to 36 hr; survival of leukemia colony-forming cells was tested.
3